Session Information
-
WCLC 2018
19th World Conference on Lung Cancer
Conference Program for the 19th World Conference on Lung Cancer in Toronto, Canada
Download PDF of the Abstract Book: Click Here.
Presentation Date(s):- Sept 23 - 26, 2018
- Total Presentations: 2391
September 23 Sun
Sep 23 Monday
September 24 Mon
Sep 24 Tuesday
September 25 Tue
Sep 25 Wednesday
September 26 Wed
Sep 26
-
+
OA05 - Clinical Trials in IO
- 13:30 - 15:00
- 9/24/2018
- Location: Room 106
- Type: Oral Abstract Session
- Track: Advanced NSCLC
-
+
OA05.01 - Efficacy/Safety of Entinostat (ENT) and Pembrolizumab (PEMBRO) in NSCLC Patients Previously Treated with Anti-PD-(L)1 Therapy
13:30 - 13:40 | Presenter: Matthew D. Hellmann | Author(s): Pasi A Jänne, Mateusz Opyrchal, Navid Hafez, Luis E Raez, Dmitry Gabrilovich, Fang Wang, Peter Ordentlich, Susan Brouwer, Serap Sankoh, Emmett Schmidt, Michael L Meyers, Suresh S. Ramalingam
- Abstract
Loading... -
+
OA05.02 - Epacadostat Plus Pembrolizumab in Patients with Non-Small Cell Lung Cancer: Phase 1/2 Results from ECHO-202/KEYNOTE-037
13:40 - 13:50 | Presenter: Liza Villaruz | Author(s): Bryan J Schneider, Todd M. Bauer, Alexander Spira, Gina D'Amato, Jeffery Wasser, Ani Balmanoukian, Primo Lara, Anthony Olszanski, Thomas Gajewski, Sandip Patel, Ahmad Tarhini, Joshua Michael Bauml, Emmett Schmidt, Jill Bowman, Jeannie Daniel, Sherry Owens, Tara C Mitchell
- Abstract
Loading... -
+
OA05.03 - Safety and Clinical Activity of Adoptive Cell Transfer Using Tumor Infiltrating Lymphocytes (TIL) Combined with Nivolumab in NSCLC
13:50 - 14:00 | Presenter: Ben C. Creelan | Author(s): Jamie K Teer, Eric M Toloza, John E Mullinax, Ana M Landin, Jhanelle Elaine Gray, Tawee T Tanvetyanon, Matthew C Taddeo, David R Noyes, Linda L Kelley, Bin Fang, John M Koomen, Amod A Sarnaik, Sungjune Kim, Eric B. Haura, Scott J Antonia
- Abstract
Loading... -
+
OA05.04 - Discussant - OA 05.01, OA 05.02, OA 05.03
14:00 - 14:15 | Presenter: Scott Owen | Author(s): Martin J. Edelman
- Abstract
No abstract available for this presentation
-
+
OA05.05 - Avelumab vs Docetaxel for Previously Treated Advanced NSCLC: Primary Analysis of the Phase 3 JAVELIN Lung 200 Trial
14:15 - 14:25 | Presenter: Fabrice Barlesi | Author(s): Johan F. Vansteenkiste, David R. Spigel, Hidenobu Ishii, Marina Chiara Garassino, Filippo De Marinis, Mustafa Özgüroğlu, Aleksandra Szczesna, Andreas Polychronis, Ruchan Uslu, Maciej Krzakowski, Jong-Seok Lee, Luana Calabro, Osvaldo Arén Frontera, Barbara Ellers-Lenz, Marcis Bajars, Mary Ruisi, Keunchil Park
- Abstract
Loading... -
+
OA05.06 - CheckMate 227: Patient-Reported Outcomes of First-Line Nivolumab + Ipilimumab in High Tumor Mutational Burden Advanced NSCLC
14:25 - 14:35 | Presenter: Julie R. Brahmer | Author(s): Michael Schenker, Ki Hyeong Lee, Mariano Provencio, Makoto Nishio, Krzysztof Lesniewski-Kmak, Randeep Sangha, Samreen Ahmed, Judith Raimbourg, Kynan Feeney, Romain Corre, Fabio Andre Franke, Eduardo Richardet, John R. Penrod, Yong Yuan, Faith Nathan, Prabhu Bhagavatheeswaran, Michael De Rosa, Fiona Taylor, Rachael Lawrance, Martin Reck
- Abstract
Loading... -
+
OA05.07 - IMpower132: PFS and Safety Results with 1L Atezolizumab + Carboplatin/Cisplatin + Pemetrexed in Stage IV Non-Squamous NSCLC
14:35 - 14:45 | Presenter: Vassiliki A Papadimitrakopoulou | Author(s): Manuel Cobo, Rodolfo Bordoni, Pascale Dubray-Longeras, Zsuzsanna Szalai, Grigoriy Ursol, Silvia Novello, Francisco Orlandi, Simon Ball, Jerome Goldschmidt Jr., Rachel E Sanborn, Tien Hoang, Diana Mendus, Yu Deng, Marcin Kowanetz, Xiaohui Wen, Wei Lin, Alan Sandler, Makoto Nishio
- Abstract
Loading... -
+
OA05.08 - Discussant - OA 05.05, OA 05.06, OA 05.07
14:45 - 15:00 | Presenter: Hossein Borghaei
- Abstract
No abstract available for this presentation
-
+
OA06 - Early Stage Lung Cancer: Outcomes and Interventions
- 13:30 - 15:00
- 9/24/2018
- Location: Room 202 BD
- Type: Oral Abstract Session
- Track: Treatment of Early Stage/Localized Disease
-
+
OA06.01 - Case-Series Study in Ever- and Never-Smoking Females and Males with NSCLC: Exposures, Tumor Factors, Biology and Survival (SWOG S0424)
13:30 - 13:40 | Presenter: Kathy S. Albain | Author(s): Amy K. Darke, Philip Christopher Mack, Mary W. Redman, Ting-Yuan D. Cheng, James Moon, William S. Holland, Alain C. Borczuk, Christopher H. Chay, Paul T. Morris, Eric Vallieres, Robert A. Kratzke, Julian R. Molina, Jill M. Kolesar, Yuhchyau Chen, Robert M. Macrae, Seiji Matsumoto, Mary Reid, Gary R. Zirpoli, Warren Davis, Rochelle P. Ondracek, Wiam Bshara, Angela R. Omilian, David R. Gandara, Karen Kelly, Regina M. Santella, Christine B. Ambrosone
- Abstract
Loading... -
+
OA06.02 - Video-Assisted Thoracoscopic Surgery vs. Thoracotomy for Non-Small Cell Lung Cancer: Oncologic Outcome of a Randomized Trial
13:40 - 13:50 | Presenter: Dongrong Situ | Author(s): Hao Long, Qunyou Tan, Qingquan Luo, Zheng Wang, Gening Jiang, Tie-Hua Rong
- Abstract
Loading... -
+
OA06.03 - Sublobar Resection is Equivalent to Lobectomy for Screen Detected Lung Cancer
13:50 - 14:00 | Presenter: Brendon Stiles | Author(s): Mohamed K Hussein, Mohamed Rahouma, Benjamin Lee, Sebron Harrison, Jeffrey L. Port, Nasser Altorki
- Abstract
Loading... -
+
OA06.04 - Discussant - OA 06.01, OA 06.02, OA 06.03
14:00 - 14:15 | Presenter: Valerie W Rusch
- Abstract
No abstract available for this presentation
-
+
OA06.05 - Do SBRT Planning and Delivery Factors Influence Local Control for Early Stage Non-Small Cell Lung Cancer (e-NSCLC)?
14:15 - 14:25 | Presenter: Gregory M.M. Videtic | Author(s): Chandana A. Reddy, Aditya Juloori, Bindu Manyam, Neil M Woody, Kevin L Stephans
- Abstract
Loading... -
+
OA06.06 - MISSILE-NSCLC: A Phase II Trial Measuring the Integration of Stereotactic Radiotherapy Plus Surgery in Early-Stage Non-Small Cell Lung Cancer
14:25 - 14:35 | Presenter: David Palma | Author(s): Alexander Louie, Richard Malthaner, Dalilah Fortin, George Rodrigues, Brian Yaremko, Joanna M Laba, Keith Kwan, Stewart Gaede, Ting Lee, Aaron Ward, Andrew Warner, Richard Inculet
- Abstract
Loading... -
+
OA06.07 - Predictors and Consequences of Refusing Surgery for Clinical Stage I NSCLC: A National Cancer Database Analysis
14:35 - 14:45 | Presenter: Brendon Stiles | Author(s): Mohamed Rahouma, Mohamed Kamel, Abu Nasar, Sebron Harrison, Benjamin Lee, Jeffrey L. Port, Nasser Altorki
- Abstract
Loading... -
+
OA06.08 - Discussant - OA 06.05, OA 06.06, OA 06.07
14:45 - 15:00 | Presenter: Steven H Lin
- Abstract
No abstract available for this presentation
-
+
PC02 - Debate on Local Therapies for Limited Small Cell Lung Cancer? Surgery PRO/CON and BID Radiation PRO/CON
- 13:30 - 15:00
- 9/24/2018
- Location: Room 203 BD
- Type: Pro-Con Session
- Track: Small Cell Lung Cancer/NET
-
+
PC02.00 - Introduction with Poll Questions
13:30 - 13:35 | Presenter: Quincy Chu, Wilfried Eberhardt
- Abstract
No abstract available for this presentation
-
+
PC02.01 - Surgery - PRO
13:35 - 13:55 | Presenter: Elliot Wakeam
- Abstract
No abstract available for this presentation
-
+
PC02.02 - Surgery - CON
13:55 - 14:15 | Presenter: Cecile Le Pechoux
- Abstract
No abstract available for this presentation
-
+
PC02.02a - Poll Questions
14:15 - 14:20 | Presenter: Quincy Chu, Wilfried Eberhardt
- Abstract
No abstract available for this presentation
-
+
PC02.03 - BID Radiation - CON
14:20 - 14:40 | Presenter: Ben Slotman
- Abstract
No abstract available for this presentation
-
+
PC02.04 - BID Radiation - PRO
14:40 - 15:00 | Presenter: Jeffrey Bogart
- Abstract
No abstract available for this presentation
-
+
MA08 - Clinical Trials in Brain Metastases
- 15:15 - 16:45
- 9/24/2018
- Location: Room 203 BD
- Type: Mini Oral Abstract Session
- Track: Advanced NSCLC
-
+
MA08.01 - Phase 3 Trial of Whole Brain Radiotherapy with Concurrent Erlotinib Versus WBRT Alone for NSCLC with Brain Metastases (ENTER)
15:15 - 15:20 | Presenter: ZhenZhou Yang | Author(s): Yan Zhang, RongQing Li, Abulimiti Yisikandaer, BiYong Ren, JianGuo Sun, JianJun Li, Long Chen, Ren Zhao, JuYing Zhang
- Abstract
Loading... -
+
MA08.02 - Prophylactic Cranial Irradiation Reduces the Risk of Brain Metastases in High-Risk Lung Cancer Patients: EGFR and ALK Mutations
15:20 - 15:25 | Presenter: Oscar Arrieta | Author(s): Federico Maldonado, Laura-Alejandra Ramírez-Tirado, Feliciano Barron, Yelitza Esmeralda Campos-Salgado, Monica Blake, Andrés F. Cardona, Jaime G De La Garza
- Abstract
Loading... -
+
MA08.03 - EGFR-TKI Plus Brain Radiotherapy Versus EGFR-TKI Alone in the Management of EGFR Mutated NSCLC Patients with Brain Metastases: A Meta-Analysis
15:25 - 15:30 | Presenter: Wenhua Liang | Author(s): Xiaojun Xia, Minzhang Guo, Jianxing He
- Abstract
Loading... -
+
MA08.04 - Discussant - MA 08.01, MA 08.02, MA 08.03
15:30 - 15:45 | Presenter: Nasser Hanna
- Abstract
No abstract available for this presentation
-
+
MA08.05 - Brain Penetration of Lorlatinib and Cumulative Incidence Rates for CNS and Non CNS Progression from a Phase 1/2 Study
15:45 - 15:50 | Presenter: Todd M. Bauer | Author(s): Alice T. Shaw, Melissa L. Johnson, Alejandro Navarro, Justin F Gainor, Holger Thurm, Yazdi K. Pithavala, Antonello Abbattista, Enriqueta Felip
- Abstract
Loading... -
+
MA08.07 - Real World Data of Osimertinib in Patients with Central Nervous System (CNS) Metastasis in ASTRIS Korean Subset.
15:50 - 15:55 | Presenter: Jin-Hyoung Kang | Author(s): Byoung Chul Cho, Dong-Wan Kim, Keunchil Park, Jong-Seok Lee, Seung soo Yoo, Sung Yong Lee, Cheol Hyeon Kim, Seung Hun Jang, Young-Chul Kim, Hyoung-Kyu Yoon, Sang-We Kim
- Abstract
Loading... -
+
MA08.08 - Discussant - MA 08.05, MA 08.07
15:55 - 16:10 | Presenter: Myung-Ju Ahn
- Abstract
No abstract available for this presentation
-
+
MA08.09 - Impact of Brain Metastases in Immune Checkpoint Inhibitors (ICI) Treated Advanced Non-Small Cell Lung Cancer (NSCLC) Patients
16:10 - 16:15 | Presenter: Lizza Hendriks | Author(s): Clémence Henon, Eduard Auclin, Laura Mezquita, Roberto Ferrara, Clarisse Audigier-Valette, Julien Mazieres, Corentin Lefebvre, Sylvestre le Moulec, Sophie Cousin, Boris Duchemann, Cecile Le Pechoux, Angela Botticella, Samy Ammari, Anas Gazzah, Caroline Caramella, Julien Adam, David Planchard, Dirk De Ruysscher, Anne-Marie C. Dingemans, Benjamin Besse
- Abstract
Loading... -
+
MA08.10 - Real-Life Intracerebral Efficacy of Nivolumab in Non-Small Cell Lung Cancer Patients with Brain Metastases
16:15 - 16:20 | Presenter: Margaux Geier | Author(s): Renaud Descourt, Romain Corre, Guillaume Léveiller, Regine Lamy, Eric Goarant, Jean-Louis Bizec, Cyril Bernier, Gilles Quéré, Francis Couturaud, Gilles Robinet
- Abstract
Loading... -
+
MA08.11 - Early Safety Data of a Phase I/II Combining Nivolumab and Stereotactic Brain Radiosurgery for Treatment of Brain Metastases in Patients with NSCLC
16:20 - 16:25 | Presenter: Raafat Alameddine | Author(s): Philip Wong, Laura Masucci, David Roberge, Cynthia Menard, Bertrand Routy, Mustapha Tehfe, Normand Blais, Marie Florescu
- Abstract
Loading... -
+
MA08.12 - Discussant - MA 08.09, MA 08.10, MA 08.11
16:25 - 16:40 | Presenter: Arjun Sahgal
- Abstract
No abstract available for this presentation
-
+
MA08.12a - Q&A
16:40 - 16:45
- Abstract
No abstract available for this presentation
-
+
MA09 - Lung Cancer Surgical and Molecular Pathology
- 15:15 - 16:45
- 9/24/2018
- Location: Room 202 BD
- Type: Mini Oral Abstract Session
- Track: Pathology
-
+
MA09.01 - Correlation of Pre-Operative Cancer Imaging Techniques with Post-Operative Macro and Microscopic Lung Pathology Images
15:15 - 15:20 | Presenter: Stephen James Harrow | Author(s): Gabriel Reines-March, Craig Dick, Xiangyang Ju, Stephen Marshall
- Abstract
Loading... -
+
MA09.02 - Tumor Size and Frozen Section Should Be Considered Jointly to Predict the Final Pathology for Lung Adenocarcinoma
15:20 - 15:25 | Presenter: Erjia Zhu | Author(s): Chang Chen
- Abstract
Loading... -
+
MA09.03 - Multiple Pathological Variables Predict Efficacy of Adjuvant Chemotherapy in Primary Lung Adenocarcinoma
15:25 - 15:30 | Presenter: John Le Quesne | Author(s): Marco Sereno, Claire Smith, Madhumita Das, Robert Hastings, Grace Rake, David Moore
- Abstract
Loading... -
+
MA09.04 - Discussant - MA 09.01, MA 09.02, MA 09.03
15:30 - 15:45 | Presenter: Natasha Rekhtman
- Abstract
No abstract available for this presentation
-
+
MA09.05 - Can We Predict Radiosensitivity in Non-Small Cell Lung Cancer?
15:45 - 15:50 | Presenter: Juvenal Baena | Author(s): Christopher Talbot, John Le Quesne
- Abstract
Loading... -
+
MA09.06 - The Newly Recognized Filigree Pattern of Micropapillary (MIP) Lung Adenocarcinoma (LADC) is as Clinically Important as the Classical Pattern
15:50 - 15:55 | Presenter: Katsura Emoto | Author(s): Takashi Eguchi, Raj G. Vaghjiani, Yusuke Takahashi, Natasha Rekhtman, Prasad S. Adusumilli, William D Travis
- Abstract
Loading... -
+
MA09.07 - Developing a Pathological Grading System in Predicting Prognosis for Invasive Mucinous Adenocarcinomas
15:55 - 16:00 | Presenter: Wei-Chin Chang | Author(s): Yu Zhi Zhang, Eric Lim, Andrew G Nicholson
- Abstract
Loading... -
+
MA09.08 - Discussant - MA 09.05, MA 09.06, MA 09.07
16:00 - 16:15 | Presenter: Lucian R Chirieac
- Abstract
No abstract available for this presentation
-
+
MA09.09 - EBUS-TBNA in Assessing PD-L1 Expression in NSCLC
16:15 - 16:20 | Presenter: Jason S Agulnik | Author(s): Goulnar Kasymjanova, Hangjun Wang, Lama Sakr, David Small, Victor Cohen, Alan Spatz
- Abstract
Loading... -
+
MA09.10 - Molecular Profiling and PD-L1 Status in 900 Cases of Surgically Resected Non-Small Cell Lung Cancer with Clinical and Pathological Correlation
16:20 - 16:25 | Presenter: Zhaolin Xu | Author(s): Mathieu Castonguay, Wenda Greer, Akram Alwithenani, Drew Bethune, Arik Drucker, Gordon Flowerdew, Marika Forsythe, Daniel French, Harry Henteleff, Michael Johnston, Mary Macneil, Wojciech Morzycki, Madelaine Plourde, Stephanie Snow, Alexi Surette
- Abstract
Loading... -
+
MA09.11 - Genomic Landscape and its Correlation with TMB, CD8 TILs and PD-L1 Expression in Chinese Lung Squamous Cell Carcinoma
16:25 - 16:30 | Presenter: Tao Jiang | Author(s): Jinpeng Shi, Chunyan Wu, Henghui Zhang, Caicun Zhou
- Abstract
Loading... -
+
MA09.12 - Discussant - MA 09.09, MA 09.10, MA 09.11
16:30 - 16:45 | Presenter: Philippe Joubert
- Abstract
No abstract available for this presentation
-
+
MS09 - Tumour Board - Tissue Acquisition and Staging
- 15:15 - 16:45
- 9/24/2018
- Location: Room 206 BD
- Type: Mini Symposium
- Track: Interventional Diagnostics/Pulmonology
-
+
MS09.01 - Cases Prepared by Drs. Edell/Murgu
15:15 - 16:35 | Presenter: Neal Navani, Karin Steinke, Kazuhiro Yasufuku, David Hwang, Septimiu Murgu, Eric Edell
- Abstract
No abstract available for this presentation
-
+
MS09.05 - Q&A
16:35 - 16:45
- Abstract
No abstract available for this presentation
-
+
MS10 - Part Solid Nodules, GGN and STAS
- 15:15 - 16:45
- 9/24/2018
- Location: Room 206 F
- Type: Mini Symposium
- Track: Treatment of Early Stage/Localized Disease
-
+
MS10.01 - Radiographic Differences Between Presumed AIS and MIA
15:15 - 15:30 | Presenter: Mini Pakkal
- Abstract
No abstract available for this presentation
-
+
MS10.02 - Importance of CT in the Pathologic Assessment of Tumor Sized in Subsolid and Part-Solid Adenocarcinoma
15:30 - 15:45 | Presenter: Erik Thunnissen
- Abstract
No abstract available for this presentation
-
+
MS10.03 - CT Versus Needle Biopsy Assessment Before Resection of Part Solid Nodules
15:45 - 16:00 | Presenter: Young Tae Kim
- Abstract
No abstract available for this presentation
-
+
MS10.04 - Therapeutic Implications of Spread Through Air Spaces (STAS)
16:00 - 16:15 | Presenter: William D Travis | Author(s): Rania Gaber, Shaohua Lu, Takashi Eguchi, Natasha Rekhtman, Prasad S. Adusumilli
- Abstract
No abstract available for this presentation
-
+
MS10.05 - Should We Resect GGNs
16:15 - 16:30 | Presenter: Kenji Suzuki
- Abstract
No abstract available for this presentation
-
+
MS10.06 - Q&A
16:30 - 16:45
- Abstract
No abstract available for this presentation
-
+
MS11 - Stigma and Lung Cancer: Unintended Translational Consequences of Effective Tobacco Control
- 15:15 - 16:45
- 9/24/2018
- Location: Room 206 AC
- Type: Mini Symposium
- Track: Prevention and Tobacco Control
-
+
MS11.01 - Identifying Consequences of Stigma on Lung Cancer Care Delivery and Patient Outcomes
15:15 - 15:35 | Presenter: Heidi Hamann
- Abstract
No abstract available for this presentation
-
+
MS11.02 - Stigma of Tobacco and Lung Cancer: A South American Perspective
15:35 - 15:55 | Presenter: Clarissa Baldotto
- Abstract
No abstract available for this presentation
-
+
MS11.03 - Prevalence of Perceived Lung Cancer Stigma Among Medical and Nursing Students
15:55 - 16:15 | Presenter: Jamie L Studts
- Abstract
No abstract available for this presentation
-
+
MS11.04 - Taking a Smoking History in the Context of Lung Cancer Treatment: Missed Opportunities for Stigma-Reducing Empathic Encounters with Throacic Oncologists
16:15 - 16:35 | Presenter: Peter G Harper
- Abstract
No abstract available for this presentation
-
+
MS11.05 - Q&A
16:35 - 16:45
- Abstract
No abstract available for this presentation
-
+
MS12 - Immunotherapy and RT
- 15:15 - 16:45
- 9/24/2018
- Location: Room 105
- Type: Mini Symposium
- Track: Treatment of Locoregional Disease - NSCLC
-
+
MS12.01 - Biology IO+RT
15:15 - 15:35 | Presenter: Dirk De Ruysscher
- Abstract
No abstract available for this presentation
-
+
MS12.02 - Clinical Data Available
15:35 - 15:55 | Presenter: Feng-Ming (Spring) Kong
- Abstract
No abstract available for this presentation
-
+
MS12.03 - Ongoing Studies
15:55 - 16:15 | Presenter: Francoise Mornex
- Abstract
No abstract available for this presentation
-
+
MS12.04 - Implications for Routine Practice
16:15 - 16:35 | Presenter: Paul Mitchell
- Abstract
No abstract available for this presentation
-
+
MS12.05 - Q&A
16:35 - 16:45
- Abstract
No abstract available for this presentation
-
+
OA07 - Oligometastasis: What Should Be the State-Of-The-Art?
- 15:15 - 16:45
- 9/24/2018
- Location: Room 107
- Type: Oral Abstract Session
- Track: Oligometastatic NSCLC
-
+
OA07.01 - Phase II Study of Pembrolizumab for Oligometastatic Non-Small Cell Lung Cancer (NSCLC) Following Completion of Locally Ablative Therapy (LAT)
15:15 - 15:25 | Presenter: Joshua Michael Bauml | Author(s): Rosemarie Mick, Christine Ciunci, Charu Aggarwal, Christiana Davis, Tracey Evans, Charuhas Deshpande, Linda Miller, Pooja Patel, Evan Alley, Christina Knepley, Faith Mutale, Roger B Cohen, Corey J Langer
- Abstract
Loading... -
+
OA07.02 - ATOM: A Phase II Study to Assess Efficacy of Preemptive Local Ablative Therapy to Residual Oligometastases After EGFR TKI
15:25 - 15:35 | Presenter: Oscar S.H. Chan | Author(s): Kwok Chi Lam, Jacky Yu Chung Li, Frankie Choi, Catherine Wong, Amy Chang, Frankie Mo, Ki Wang, Rebecca Yeung, Tony S. Mok
- Abstract
Loading... -
+
OA07.03 - Addition of Local Therapy to EGFR TKI Showed Survival Benefit in EGFR-Mutant NSCLC pts with Oligometastatic or Oligoprogressive Liver Metastases
15:35 - 15:45 | Presenter: Tao Jiang | Author(s): Caicun Zhou, Huijuan Wang, Qian Chu
- Abstract
Loading... -
+
OA07.04 - Discussant - OA 07.01, OA 07.02, OA 07.03
15:45 - 16:00 | Presenter: Gregory M.M. Videtic
- Abstract
No abstract available for this presentation
-
+
OA07.05 - Local Ablative Therapy Improves Survival in Patients with Synchronous Oligometastatic NSCLC Harboring EGFR Mutation Treated with EGFR-TKIs
16:00 - 16:10 | Presenter: Yaping Xu | Author(s): Qinghua Xu, Fei Zhou, Hui Liu, Caicun Zhou
- Abstract
Loading... -
+
OA07.06 - Efficacy of Local Consolidative Therapy for Oligometastatic Lung Adenocarcinoma Patients Harboring EGFR Mutations.
16:10 - 16:20 | Presenter: Fang Hu | Author(s): Jianlin Xu, Bo Zhang, Changhui Li, Wei Nie, Ping Gu, Ping Hu, Huimin Wang, Yujun Zhang, Yinchen Shen, Shuyuan Wang, Baohui Han, Xueyan Zhang
- Abstract
Loading... -
+
OA07.07 - PFS and OS Beyond 5 years of NSCLC Patients with Synchronous Oligometastases Treated in a Prospective Phase II Trial (NCT 01282450)
16:20 - 16:30 | Presenter: Dirk De Ruysscher | Author(s): Rinus Wanders, Lizza Hendriks, Angela Van Baardwijk, Bart Reymen, Ruud Houben, Gerben Bootsma, Cordula Pitz, Anne-Marie C. Dingemans
- Abstract
Loading... -
+
OA07.08 - Discussant - OA 07.05, OA 07.06, OA 07.07
16:30 - 16:45 | Presenter: Sue S Yom
- Abstract
No abstract available for this presentation